Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2336.2 and 2401.1
| Intraday Target 1 | 2288.37 |
| Intraday Target 2 | 2319.13 |
| Intraday Target 3 | 2353.2666666667 |
| Intraday Target 4 | 2384.03 |
| Intraday Target 5 | 2418.17 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 04 May 2026 | 2349.90 (0.58%) | 2342.00 | 2322.50 - 2387.40 | 1.4184 times | Thu 30 April 2026 | 2336.40 (-1.28%) | 2367.20 | 2319.40 - 2370.80 | 1.4133 times | Wed 29 April 2026 | 2366.60 (-1.81%) | 2415.00 | 2359.50 - 2428.50 | 2.0051 times | Tue 28 April 2026 | 2410.20 (-1.19%) | 2450.00 | 2404.20 - 2466.30 | 0.6601 times | Mon 27 April 2026 | 2439.20 (-1.33%) | 2472.00 | 2427.00 - 2495.00 | 1.5145 times | Fri 24 April 2026 | 2472.00 (-0.91%) | 2496.40 | 2459.80 - 2509.60 | 0.7024 times | Thu 23 April 2026 | 2494.60 (1.18%) | 2480.00 | 2456.00 - 2529.90 | 0.8701 times | Wed 22 April 2026 | 2465.60 (1.57%) | 2420.20 | 2397.10 - 2496.00 | 0.7286 times | Tue 21 April 2026 | 2427.40 (-0.1%) | 2429.90 | 2420.10 - 2450.00 | 0.2405 times | Mon 20 April 2026 | 2429.90 (-0.98%) | 2465.00 | 2410.90 - 2466.10 | 0.4468 times | Fri 17 April 2026 | 2453.90 (1.41%) | 2419.80 | 2410.00 - 2465.40 | 0.5311 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2336.2 and 2401.1
| Weekly Target 1 | 2288.37 |
| Weekly Target 2 | 2319.13 |
| Weekly Target 3 | 2353.2666666667 |
| Weekly Target 4 | 2384.03 |
| Weekly Target 5 | 2418.17 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 04 May 2026 | 2349.90 (0.58%) | 2342.00 | 2322.50 - 2387.40 | 0.4633 times | Thu 30 April 2026 | 2336.40 (-5.49%) | 2472.00 | 2319.40 - 2495.00 | 1.8271 times | Fri 24 April 2026 | 2472.00 (0.74%) | 2465.00 | 2397.10 - 2529.90 | 0.9762 times | Fri 17 April 2026 | 2453.90 (2.5%) | 2370.10 | 2341.20 - 2468.80 | 0.8195 times | Fri 10 April 2026 | 2394.00 (3.57%) | 2307.00 | 2267.80 - 2431.80 | 0.9298 times | Thu 02 April 2026 | 2311.50 (2.3%) | 2259.50 | 2217.60 - 2401.90 | 1.2549 times | Fri 27 March 2026 | 2259.50 (-5.25%) | 2353.40 | 2255.10 - 2364.90 | 1.0208 times | Fri 20 March 2026 | 2384.80 (-1.63%) | 2413.00 | 2362.50 - 2472.00 | 0.744 times | Fri 13 March 2026 | 2424.30 (-3.69%) | 2500.00 | 2397.70 - 2554.00 | 0.9987 times | Fri 06 March 2026 | 2517.30 (-2.11%) | 2520.00 | 2450.10 - 2581.60 | 0.9656 times | Fri 27 February 2026 | 2571.60 (-0.97%) | 2616.80 | 2566.00 - 2668.80 | 0.9641 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2336.2 and 2401.1
| Monthly Target 1 | 2288.37 |
| Monthly Target 2 | 2319.13 |
| Monthly Target 3 | 2353.2666666667 |
| Monthly Target 4 | 2384.03 |
| Monthly Target 5 | 2418.17 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 04 May 2026 | 2349.90 (0.58%) | 2342.00 | 2322.50 - 2387.40 | 0.0748 times | Thu 30 April 2026 | 2336.40 (2.34%) | 2305.00 | 2261.90 - 2529.90 | 0.8527 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.6871 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 1.0026 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.8956 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.4636 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.2208 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.7927 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.2627 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.7475 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 1.0669 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2032.65 and 2534.85
| Yearly Target 1 | 1926.9 |
| Yearly Target 2 | 2138.4 |
| Yearly Target 3 | 2429.1 |
| Yearly Target 4 | 2640.6 |
| Yearly Target 5 | 2931.3 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Mon 04 May 2026 | 2349.90 (-5%) | 2476.00 | 2217.60 - 2719.80 | 0.2987 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6323 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2379 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.244 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7226 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9638 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0756 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4601 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.234 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1309 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1311 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in downtrend.
And this trend seems to be continuing further.Price is below an important level of 2397.9 on charts, and if price remains below this level, then stock might show a fall in short term.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 30 as on Mon 04 May 2026
This Munafa value indicates that the stock is moving downwards and might continue to move down.
SMA20 is at 2400 and price is deviating by 51 points
Upper Bollinger band is at 2501 and lower is at 2298, while middle bands are at 2349 and 2451
Price is rising
Price is below 20day SMA
Price is in upper range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and the sell signal is strong.
GlaxosmithklinePharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2403.88 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2380.46 |
| 12 day DMA | 2422.13 |
| 20 day DMA | 2399.22 |
| 35 day DMA | 2391.41 |
| 50 day DMA | 2446 |
| 100 day DMA | 2458.37 |
| 150 day DMA | 2517.31 |
| 200 day DMA | 2613.09 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2375.93 | 2388.94 | 2415.2 |
| 12 day EMA | 2397.93 | 2406.66 | 2419.43 |
| 20 day EMA | 2403.37 | 2409 | 2416.64 |
| 35 day EMA | 2433.23 | 2438.14 | 2444.13 |
| 50 day EMA | 2453.39 | 2457.61 | 2462.56 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2380.46 | 2404.88 | 2436.52 |
| 12 day SMA | 2422.13 | 2426.73 | 2433.22 |
| 20 day SMA | 2399.22 | 2398.19 | 2395.52 |
| 35 day SMA | 2391.41 | 2396.25 | 2401.42 |
| 50 day SMA | 2446 | 2450.89 | 2457.53 |
| 100 day SMA | 2458.37 | 2460.06 | 2461.89 |
| 150 day SMA | 2517.31 | 2519.91 | 2522.71 |
| 200 day SMA | 2613.09 | 2617.88 | 2622.5 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 60.27 and PE is: 38.99
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
EPS is 56.39 and PE is: 41.67
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
